Camille Sarrazyn Email Camille.Sarrazyn@UGent.be 1 – 3 of 3 publications Show 10 5 10 15 20 50 100 250 Sort by year (new to old) Actions Filter publications Save this search Download search results Subscribe to news feed Add to list Journal Article A1 open access Incidence, risk factors, timing and outcome of influenza versus Covid-19 associated putative invasive aspergillosis Camille Sarrazyn, Sofie Dhaese, Birgit Demey, Stefaan Vandecasteele, Marijke Reynders and Jens Van Praet (UGent) (2021) INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY. 42(9). p.1149-1150 Add to list Journal Article A1 Patient- versus physician-reported outcomes in prostate cancer patients receiving hypofractionated radiotherapy within a randomized controlled trial Elke Rammant (UGent) , Piet Ost (UGent) , Martijn Swimberghe (UGent) , Barbara Vanderstraeten (UGent) , Nicolaas Lumen (UGent) , Karel Decaestecker (UGent) , Renée Bultijnck (UGent) , Gert De Meerleer, Camille Sarrazyn, Roos Colman (UGent) , et al. (2019) STRAHLENTHERAPIE UND ONKOLOGIE. 195(5). p.393-401 Add to list Journal Article A1 4 Weeks versus 5 weeks of hypofractionated high-dose radiation therapy as primary therapy for prostate cancer : interim safety analysis of a randomized phase 3 trial Valerie Fonteyne (UGent) , Camille Sarrazyn, Martijn Swimberghe (UGent) , Gert De Meerleer, Elke Rammant (UGent) , Barbara Vanderstraeten (UGent) , Frank Vanpachtenbeke (UGent) , Nicolaas Lumen (UGent) , Karel Decaestecker (UGent) , Roos Colman (UGent) , et al. (2018) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 100(4). p.866-870